A1

Ágnes Paál1,2,3,4, David Dora5, Ákos Takács1,2

  • 1Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1085 Budapest, Hungary.

Cancers
|May 14, 2025
PubMed
概括

附录素A1 (ANXA1) 与小细胞肺癌 (SCLC) 免疫细胞增加和治疗耐药性有关. 沉默ANXA1降低了化疗敏感性,这表明ANXA1是SCLC的潜在治疗点.